Company
United StatesNoramco, Inc., Wilmington, DE – FDA Inspections
Inspection records and compliance data for Noramco, Inc. in Wilmington, Delaware. 8 FDA inspections on record, 1 Form 483, last inspected October 15, 2025.
Company Profile
This profile covers Noramco, Inc. based in Wilmington, Delaware, United States.
FDA Inspection History
- FDA inspections
- 8
- OAI
- 0
- VAI
- 2
- NAI
- 5
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 2, 2010. Last inspected October 15, 2025.
FDA inspections (8)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 15, 2025 | Not classified | Human Drugs | 1287192 |
| November 18, 2022 | NAI | Human Drugs · Drug Quality Assurance | 1194573 |
| February 21, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1083841 |
| November 17, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1032329 |
| January 21, 2016 | NAI | Human Drugs · Drug Quality Assurance | 956500 |
| November 13, 2014 | NAI | Human Drugs · Drug Quality Assurance | 903718 |
| April 27, 2012 | NAI | Human Drugs · Drug Quality Assurance | 778983 |
| August 2, 2010 | VAI | Human Drugs · Drug Quality Assurance | 674165 |
FDA documents
Form 483s (1)
EIRs (1)
People (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Noramco, Inc.
FEI Number
2522445
Address
500 Swedes Landing Rd, Wilmington, Delaware 19801, United States
Country
United States
ID: 8af3944b-5c06-49e7-813b-71cf3dd72be6